JP2009533466A5 - - Google Patents

Download PDF

Info

Publication number
JP2009533466A5
JP2009533466A5 JP2009505565A JP2009505565A JP2009533466A5 JP 2009533466 A5 JP2009533466 A5 JP 2009533466A5 JP 2009505565 A JP2009505565 A JP 2009505565A JP 2009505565 A JP2009505565 A JP 2009505565A JP 2009533466 A5 JP2009533466 A5 JP 2009533466A5
Authority
JP
Japan
Prior art keywords
nucleotides
seq
interfering rna
mrna
strand
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009505565A
Other languages
English (en)
Japanese (ja)
Other versions
JP5473594B2 (ja
JP2009533466A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/066287 external-priority patent/WO2007121156A2/en
Publication of JP2009533466A publication Critical patent/JP2009533466A/ja
Publication of JP2009533466A5 publication Critical patent/JP2009533466A5/ja
Application granted granted Critical
Publication of JP5473594B2 publication Critical patent/JP5473594B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009505565A 2006-04-13 2007-04-10 ヒスタミン受容体Ｈ１関連状態のＲＮＡｉ介在型阻害 Expired - Fee Related JP5473594B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US79162306P 2006-04-13 2006-04-13
US60/791,623 2006-04-13
PCT/US2007/066287 WO2007121156A2 (en) 2006-04-13 2007-04-10 Rnai-mediated inhibition of histamine receptor h1-related conditions

Publications (3)

Publication Number Publication Date
JP2009533466A JP2009533466A (ja) 2009-09-17
JP2009533466A5 true JP2009533466A5 (enExample) 2010-01-07
JP5473594B2 JP5473594B2 (ja) 2014-04-16

Family

ID=38610324

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009505565A Expired - Fee Related JP5473594B2 (ja) 2006-04-13 2007-04-10 ヒスタミン受容体Ｈ１関連状態のＲＮＡｉ介在型阻害

Country Status (6)

Country Link
US (5) US8017592B2 (enExample)
EP (2) EP2674493B1 (enExample)
JP (1) JP5473594B2 (enExample)
AR (1) AR060449A1 (enExample)
TW (1) TW200808361A (enExample)
WO (1) WO2007121156A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2674493B1 (en) 2006-04-13 2017-12-27 Arrowhead Research Corporation RNAi-mediated inhibition of histamine receptor H1-related conditions
US10787664B2 (en) * 2015-05-26 2020-09-29 City Of Hope Compounds of chemically modified oligonucleotides and methods of use thereof
JP7030716B2 (ja) * 2016-05-09 2022-03-07 バイオガイア・エイビー アレルギー治療に有用な細菌株の選択
EP4306655A4 (en) * 2021-08-04 2024-08-21 Hangzhou Zheda Dixun Biological Gene Engineering Co., Ltd PRIMER-PROBE SET, KIT AND DETECTION METHOD FOR DETECTING HUMAN HISTAMINE RECEPTOR HRH1 mRNA
CN113604557A (zh) * 2021-08-04 2021-11-05 杭州浙大迪迅生物基因工程有限公司 一种人组胺受体HRH1 mRNA检测引物探针组、试剂盒和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2305813A3 (en) * 2002-11-14 2012-03-28 Dharmacon, Inc. Fuctional and hyperfunctional sirna
WO2006006948A2 (en) * 2002-11-14 2006-01-19 Dharmacon, Inc. METHODS AND COMPOSITIONS FOR SELECTING siRNA OF IMPROVED FUNCTIONALITY
AU2003224132A1 (en) * 2003-04-24 2004-11-19 Galapagos Genomics N.V. Effective sirna knock-down constructs
EP1648997A2 (en) * 2003-07-11 2006-04-26 Oregon Health and Science University Methods of treatment and disgnosis using modulators of virus-induced cellular gene sequences
JPWO2005028667A1 (ja) * 2003-09-19 2006-11-30 独立行政法人理化学研究所 ヒト肥満細胞で発現するｇ蛋白質共役型受容体を標的とした薬剤およびそのスクリーニング方法
CA2566286A1 (en) * 2004-05-11 2005-12-08 Rnai Co., Ltd. Polynucleotide causing rna interfere and method of regulating gene expression with the use of the same
US20070213286A1 (en) * 2005-09-12 2007-09-13 The Trustees Of Columbia University In The City Of New York Inhibitors of dynein or lissencephaly 1, and methods of using same for treatment of neuronal disorders
EP2674493B1 (en) * 2006-04-13 2017-12-27 Arrowhead Research Corporation RNAi-mediated inhibition of histamine receptor H1-related conditions

Similar Documents

Publication Publication Date Title
RU2008150324A (ru) Iphk-опосредованное ингибирование связанных с фактором некроза опухоли альфа состояний
RU2008130857A (ru) Опосредованное phkи ингибирование hif1a для лечения глазного ангиогенеза
RU2011124528A (ru) ОПОСРЕДОВАННОЕ PHKI ИНГИБИРОВАНИЕ Rho-КИНАЗЫ ДЛЯ ЛЕЧЕНИЯ ГЛАЗНЫХ НАРУШЕНИЙ
CN108136206B (zh) 抗乙型肝炎病毒的组合物和药剂及其用途
JP2010501188A5 (enExample)
JP2008525460A5 (enExample)
RU2007132848A (ru) Опосредуемое rnai ингибирование мишеней глаза
CA2946719C (en) Una oligomers having reduced off-target effects in gene silencing
JP2009533475A5 (enExample)
JP2017519766A5 (enExample)
JP2010539950A5 (enExample)
HRP20201200T1 (hr) OLIGONUKLEOTIDNI SPOJEVI ZA CILJANJE HUNTINGTIN mRNK
US20160076037A1 (en) Modified tgf-beta oligonucleotides
EP2759595B1 (en) Composition comprising an encapsulated antagomir
WO2009004085A3 (en) Dsrna for treating viral infection
JP2016523548A5 (enExample)
JP2022533358A5 (enExample)
JP2018521669A (ja) 治療用オリゴヌクレオチド
WO2016030899A1 (en) Methods of treating amyotrophic lateral scleroses
JP2017510583A (ja) 遺伝子サイレンシング用トランスサイレチン対立遺伝子選択的ｕｎａオリゴマー
US8338583B2 (en) Snornai-small nucleolar RNA degradation by RNA interference in trypanosomatids
JP2024529875A5 (enExample)
RU2013121802A (ru) Профилактический или терапевтический агент для лечения фиброза
JP2016518820A5 (enExample)
JP2007530431A5 (enExample)